AbbVie subsidiary Forest faces more antitrust litigation over Alzheimer's drug as judge rejects its bid to toss case - FiercePharma

Submitted by Anonymous (not verified) on Mon, 06/14/2021 - 15:19

AbbVie subsidiary Forest faces more antitrust litigation over Alzheimer's drug as judge rejects its bid to toss case  FiercePharma